Abstract The SARS-CoV-2, a highly infectious positive strand RNA virus first identified in
December 2019, has produced multiple genetic variants that have rapidly and sequentially …

Background Whole-genome sequencing (WGS) is the gold standard diagnostic tool to
identify and genetically characterise emerging pathogen mutations (variants), but cost …

Detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral genome
in wastewater has proven to be useful for tracking the trends of virus prevalence within the …

Recombination is a key molecular mechanism for the evolution and adaptation of viruses.
The first recombinant SARS-CoV-2 genomes were recognized in 2021; as of today, more …

The on‐going emergence of the Omicron BA. 2.86 variant is one of the major events in
SARS‐CoV‐2 genetic evolution that remain enigmatic regarding the overall virus mutation …

Severe acute respiratory syndrome coronavirus 2 XBB. 1.5 is the first recombinant lineage to
predominate at the country and global scales. Very interestingly, like the Marseille‐4B …

Globally, the continuous spread and evolution of SARS-CoV-2, along with its variants,
profoundly impact human well-being, health, security, and the growth of socio-economic. In …

Introduction Epitopes are specific structures in antigens that are recognized by the immune
system. They are widely used in the context of immunology-related applications, such as …

The global prevalence of the XBB lineage presents a formidable challenge posed by the
recombinant SARS-CoV-2 virus. The understanding of SARS-CoV-2's recombination …

Additional mutations in the viral Spike protein helped the BA. 2.12. 1 and BA. 4/5 SARS-CoV-
2 Omicron subvariants to outcompete the parental BA. 2 subvariant. Here, we determined …